|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities | |||||
| Depreciation | |||||
| Amortization of other assets | |||||
| Origination of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Net (gain) on sales of loans | |||||
| Provision for credit losses | |||||
| (Gain) on sale of portfolio loans | |||||
| Loss on sale of other real estate owned | |||||
| (Gain) on the sale of marine finance assests | |||||
| Loss (gain) on the sale and disposal of premises and equipment | |||||
| Loss on the sale of repossessed assets | |||||
| Loss on the sale of securities | |||||
| Amortization of subordinated debt issuance costs | |||||
| Stock-based compensation expense | |||||
| Premium amortization on securities, net | |||||
| (Accretion) amortization of premiums and discounts on debt securities and loans, net | |||||
| Bank owned life insurance income | |||||
| (Gain) on bank-owed life insurance settlement | |||||
| Deferred tax accrual | |||||
| Changes in assets and liabilities: | |||||
| Decrease in other assets | |||||
| Increase in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Proceeds from maturities, calls, and principal payments of securities available for sale | |||||
| Proceeds from the sale of securities available for sale | |||||
| Purchases of securities available for sale | |||||
| Proceeds from the sale of restricted investments | |||||
| Purchase of restricted investments | |||||
| Proceeds from bank-owned life insurance settlement | |||||
| Proceeds from the sale of bank premises and equipment | |||||
| Purchases of bank premises and equipment | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from the sale of other real estate owned | |||||
| Proceeds from the sale of repossessed assets | |||||
| Changes in collateral posted with other financial institutions, net | |||||
| Proceeds from sale of marine finance assets | |||||
| Proceeds from the sale of portfolio loans | |||||
| Origination of loans, net of prinicpal collected | |||||
| Funding of capital commitments related to other investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Net increase (decrease) in demand deposits, money market and savings accounts | |||||
| Net (decrease) increase in certificates of deposit | |||||
| Net (decrease) in federal funds purchased | |||||
| Advances of long-term Federal Home Loan Bank advances | |||||
| Issuance of subordinated debt, net of issuance costs | |||||
| Net (decrease) increase in short-term Federal Home Loan Bank advances | |||||
| Repayment) of long-term Federal Home Loan Bank advances | |||||
| Issuance of common stock, employee benefit plan | |||||
| Net proceeds from issuance of common stock in public offering | |||||
| Repurchase and retirement of common stock | |||||
| Cash dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Increase in cash and cash equivalents | |||||
| Cash and Cash Equivalents | |||||
| Beginning | |||||
| Ending | |||||
| Supplemental Disclosures of Cash Flow Information | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental Schedule of Noncash Investing and Financing Activities: | |||||
| Unrealized (loss) gain on securities available for sale | |||||
| Minimum postretirement liability adjustment | |||||
| Real estate and repossessed assets acquired in settlement of loans | |||||
| Issuance of common stock, dividend investment plan | |||||
| Lease liabilities arising from right-of-use assets | |||||
Loading...
